Premium
P4‐664: A PHASE 1 STUDY OF AL001 IN HEALTHY VOLUNTEERS AND FRONTOTEMPORAL DEMENTIA PATIENTS CARRYING A GRANULIN MUTATION
Author(s) -
Paul Robert,
Ward Michael,
Siddiqui Omer,
Hagey Mackenzie,
Long Hua,
King Robert,
Schwabe Tina,
Kurnellas Michael,
Lu Shiao-Ping,
Rosenthal Ar
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.09.030
Subject(s) - frontotemporal dementia , tolerability , cerebrospinal fluid , medicine , adverse effect , placebo , pharmacodynamics , pharmacokinetics , oncology , clinical trial , pharmacology , dementia , pathology , disease , alternative medicine